Doximity, Inc. (NASDAQ:DOCS) Stock Position Lifted by Venturi Wealth Management LLC

Venturi Wealth Management LLC raised its stake in Doximity, Inc. (NASDAQ:DOCS) by 20,421.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 5,746 shares of the company’s stock after purchasing an additional 5,718 shares during the quarter. Venturi Wealth Management LLC’s holdings in Doximity were worth $307,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCS. Creative Planning grew its holdings in shares of Doximity by 13.7% during the 3rd quarter. Creative Planning now owns 22,104 shares of the company’s stock valued at $963,000 after acquiring an additional 2,671 shares in the last quarter. Bleakley Financial Group LLC purchased a new position in Doximity in the third quarter valued at about $213,000. Blue Trust Inc. grew its stake in Doximity by 107.2% in the third quarter. Blue Trust Inc. now owns 2,870 shares of the company’s stock valued at $125,000 after purchasing an additional 1,485 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in Doximity by 4.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 21,754 shares of the company’s stock worth $948,000 after purchasing an additional 934 shares during the last quarter. Finally, State of Alaska Department of Revenue raised its stake in shares of Doximity by 7.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 14,240 shares of the company’s stock worth $620,000 after purchasing an additional 985 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Truist Financial boosted their price target on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research note on Thursday, November 14th. Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. The Goldman Sachs Group raised their price target on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and lifted their price objective for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Finally, Mizuho increased their target price on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Down 2.1 %

Shares of NASDAQ DOCS opened at $75.10 on Friday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a market cap of $14.02 billion, a P/E ratio of 75.10, a P/E/G ratio of 4.26 and a beta of 1.39. The business’s 50 day moving average is $59.79 and its two-hundred day moving average is $48.73.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 37.40% of the stock is currently owned by corporate insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.